Yudan Zhao

Yudan Zhao

Auto-generated profile, based on publicly available information

Yudan Zhao

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YZYudan Zhao
Yudan Zhao
WYWanyue Yang
Wanyue Yang
XZXin Zhang
Xin Zhang
CLChongning Lv
Chongning Lv
JLJincai Lu
Jincai Lu

19 August 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CLChangyang Lei
Changyang Lei
PCPeiying Chen
Peiying Chen
ZZZonghui Zhang
Zonghui Zhang
FHFangcong Hua
Fangcong Hua
XHXiaohong Hou
Xiaohong Hou
QHQi Hu
Qi Hu

29 December 2025 in Pharmacological Research
Verified
Journal Article
Open access
YZYudan Zhao
Yudan Zhao
HLHongyuan Lu
Hongyuan Lu
XJXiaowen Jiang
Xiaowen Jiang
With the global population growing and aging, along with increasing environmental, metabolic, and lifestyle-related risk factors, the worldwide incidence of stroke, Alzheimer's disease (AD) and other dementias, meningitis, and other neurological disorders-along with associated mortality-has risen significantly. Proanthocyanidins (PCs), which are oligomers and polymers of flavan-3-ols, are widely distributed across the plant kingdom, including in grape seeds, cinnamon, apples, cranberries, lotus seeds, and pine bark. They represent the second most abundant class of polyphenols in nature, after lignin. A substantial body of preclinical evidence indicates that PCs exert significant neuroprotective effects through multiple mechanisms. This review provides a systematic overview of the sources, structural characteristics, and bioavailability of PCs, with a focus on their pharmacological mechanisms in nervous system disease. Specifically, it examines their roles in regulating oxidative stress, neuroinflammation, protein homeostasis, apoptosis, autophagy, and key signaling pathways, including Nrf2/HO-1, CREB/BDNF, PI3K/Akt, MAPK, and NF-κB. Furthermore, this review systematically summarized the distinct structural forms of PCs, including monomers, dimers, trimers, and polymers, and explores their structure-activity relationships (SARs) in modulating the gut-brain axis. Additionally, recent advances in PCS-based nano-delivery systems and clinical studies related to neurological disorders are summarized. Growing evidence indicates that microbial metabolism in the gut serves as a key mechanism underlying their neuroprotective effects. Finally, the potential applications of PCs as promising dietary supplements or therapeutic agents for the prevention and treatment of nervous system diseases are discussed, along with existing challenges and future perspectives.

3 January 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MYMingyuan Yuan
Mingyuan Yuan
BZBingxin Zhang
Bingxin Zhang
KHKexin Huang
Kexin Huang
YWYufei Wang
Yufei Wang
YZYudan Zhao
Yudan Zhao
XZXiaoshu Zhang
Xiaoshu Zhang

22 June 2024 in Physiology & Behavior
Verified
Journal Article
Closed access
ZMZhixuan Mao
Zhixuan Mao
CLChongning Lv
Chongning Lv
RQRulan Qin
Rulan Qin
YYYang Yu
Yang Yu
XWXiaobo Wang
Xiaobo Wang
YZYudan Zhao
Yudan Zhao